Yuchen Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuchen Wu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Guoqiang Wang
Department of Anesthesiology and Operating Theater The First Hospital of Lanzhou University Lanzhou China
3 shared publicationsHuaping Wei
Department of Anesthesiology and Operating Theater The First Hospital of Lanzhou University Lanzhou China
3 shared publicationsWeigang Yue
Lanzhou University First Affiliated Hospital, Chengguan District, Lanzhou, China
3 shared publicationsZhigang Zhang
First Hospital of Lanzhou University, Lanzhou, China
3 shared publications- Zhigang Zhang
School of Nursing, Lanzhou University, Lanzhou, China
3 shared publications Biantong Jiang
Nursing Department, Sichuan University West China Hospital, Chengdu, China
2 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1) , 1171
Perioperative esketamine-containing strategies and postoperative neurocognitive outcomes in older surgical patients: a systematic review and meta-analysis of randomized controlled trials with certainty assessment
- 14 September 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1) , 1171
Open AccessPerioperative esketamine-containing strategies and postoperative neurocognitive outcomes in older surgical patients: a systematic review and meta-analysis of randomized controlled trials with certainty assessment
- Open Access
- 31 May 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-17
Efficiency and safety of double-lumen bronchial tube and bronchial blocker for one-lung ventilation in patients with thoracic surgery: a meta-analysis
To compare the efficiency and safety of double-lumen bronchial tube (DLBT) and bronchial blocker (BB) for one-lung ventilation (OLV) in patients with thoracic surgery. A systematic search was conducted across Chinese databases and English databases from the inception of the databases until December 31, 2024. Two researchers independently screened the literature and extracted data. A meta-analysis was then performed using Review Manager 5 and Stata 18.0 software. The quality of the studies was assessed using the Cochrane bias risk assessment tool, and a summary of findings (SoF) table was generated using GRADEprofiler Version 3.6.1. A total of 39 RCTs were included, comprising 1360 patients in the BB group and 1349 patients in the DLBT group. The excellent rate of lung collapse quality in the BB group was 0.94 times that in the DLBT group [I2 = 32%, P = 0.07, fixed-effects; RR = 0.94; 95% CI (0.90, 0.99); P = 0.01]. There was no significant difference in intubation time [I2 = 97%, P < 0.00001; SMD = -0.51; 95% CI (-1.17, 0.14); P = 0.12], the success rate of first-attempt intubation [I2 = 79%, P < 0.00001; RR = 1.04; 95% CI (0.93, 1.15); P = 0.51] or in the incidence of malposition[I2 = 50%, P = 0.01; RR = 1.36; 95% CI (0.95, 1.96); P = 0.10)] between the two groups. However, there was a significant difference in positioning time, with the BB group showing shorter positioning times compared to the DLBT group [I2 = 98%, P < 0.00001; SMD = -0.85; 95% CI (-1.50, -0.21); P = 0.004]. Compared to the DLBT group, the BB group was associated with a reduced incidence of hoarseness, sore throat, tracheal mucosal injury, hypoxemia, and pneumonia. The DLBT group demonstrated certain advantages in terms of lung collapse time and quality of lung collapse. However, BB demonstrate significantly shorter positioning time compared to DLBT, and it is also associated with lower risks of multiple complications, including hoarseness, sore throat, tracheal injury, hypoxemia, and pneumonia, highlighting its safety advantage in postoperative care.
- 31 May 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-17
Open AccessEfficiency and safety of double-lumen bronchial tube and bronchial blocker for one-lung ventilation in patients with thoracic surgery: a meta-analysis
To compare the efficiency and safety of double-lumen bronchial tube (DLBT) and bronchial blocker (BB) for one-lung ventilation (OLV) in patients with thoracic surgery. A systematic search was conducted across Chinese databases and English databases from the inception of the databases until December 31, 2024. Two researchers independently screened the literature and extracted data. A meta-analysis was then performed using Review Manager 5 and Stata 18.0 software. The quality of the studies was assessed using the Cochrane bias risk assessment tool, and a summary of findings (SoF) table was generated using GRADEprofiler Version 3.6.1. A total of 39 RCTs were included, comprising 1360 patients in the BB group and 1349 patients in the DLBT group. The excellent rate of lung collapse quality in the BB group was 0.94 times that in the DLBT group [I2 = 32%, P = 0.07, fixed-effects; RR = 0.94; 95% CI (0.90, 0.99); P = 0.01]. There was no significant difference in intubation time [I2 = 97%, P < 0.00001; SMD = -0.51; 95% CI (-1.17, 0.14); P = 0.12], the success rate of first-attempt intubation [I2 = 79%, P < 0.00001; RR = 1.04; 95% CI (0.93, 1.15); P = 0.51] or in the incidence of malposition[I2 = 50%, P = 0.01; RR = 1.36; 95% CI (0.95, 1.96); P = 0.10)] between the two groups. However, there was a significant difference in positioning time, with the BB group showing shorter positioning times compared to the DLBT group [I2 = 98%, P < 0.00001; SMD = -0.85; 95% CI (-1.50, -0.21); P = 0.004]. Compared to the DLBT group, the BB group was associated with a reduced incidence of hoarseness, sore throat, tracheal mucosal injury, hypoxemia, and pneumonia. The DLBT group demonstrated certain advantages in terms of lung collapse time and quality of lung collapse. However, BB demonstrate significantly shorter positioning time compared to DLBT, and it is also associated with lower risks of multiple complications, including hoarseness, sore throat, tracheal injury, hypoxemia, and pneumonia, highlighting its safety advantage in postoperative care.
- 2 April 2025
- Published by Wiley in Nursing in Critical Care
- Vol. 30 (3) , e70018
An optimal cut‐off point for the Chelsea Critical Care Physical Assessment Tool to diagnose intensive care unit‐acquired weakness in patients with mechanical ventilation: A multicentre observational study
Background: The Chelsea Critical Care Physical Assessment Tool ( CPAx ) may be an optimal tool for diagnosing intensive care unit‐acquired weakness ( ICU ‐ AW ). However, we do not know the cut‐off point for the diagnosis of ICU ‐ AW . Aim: To ascertain the best cut‐off point for CPAx to diagnose ICU ‐ AW in adult patients with mechanical ventilation. Study Design: A multicentre, prospective cross‐sectional study. Participants were recruited from five ICUs in China that ranged from 20 June 2021 to 31 July 2023. The Medical Research Council Sum Scale ( MRC ‐ss) max ). The kappa (κ) test was used to test the consistency of the MRC ‐ss and CPAx . Results: The AUC at baseline, weaning and discharge time point was 0.87 (95% CI 0.81–0.93), 0.96 (95% CI 0.92–0.99) and 0.91 (95% CI 0.86–0.96), respectively. Correspondingly, The YImax was 0.62, 0.91 and 0.65. The best cut‐off point of CPAx score to diagnose ICU ‐ AW at baseline, weaning and discharge time point was 30.5 (sensitivity = 72%, specificity = 89%), 31.5 (sensitivity = 95%, specificity = 90%) and 31.5 (sensitivity = 94%, specificity = 71%), respectively. Due to the CPAx being an ordinal scale, it was determined preliminarily that the cut‐off point for the CPAx to diagnose ICU ‐ AW was 31 points. We took CPAx ≤31 and MRC ‐ss <48 as criteria to diagnose ICU ‐ AW and test the consistency of MRC ‐ss and CPAx . The results showed that there was no significant difference in the incidence of ICU ‐ AW at different time points. Conclusions: The optimal cut‐off point for the CPAx to diagnose ICU ‐ AW is a score of 31 and it has good sensitivity and specificity. Relevance to Clinical Practice: The CPAx ≤31 score to diagnose ICU‐acquired weakness (ICU‐AW) has good sensitivity and specificity, and it can help to predict the risk of ICU‐AW and guide medical personnel to make interventions.
- 2 April 2025
- Published by Wiley in Nursing in Critical Care
- Vol. 30 (3) , e70018
An optimal cut‐off point for the Chelsea Critical Care Physical Assessment Tool to diagnose intensive care unit‐acquired weakness in patients with mechanical ventilation: A multicentre observational study
Background: The Chelsea Critical Care Physical Assessment Tool ( CPAx ) may be an optimal tool for diagnosing intensive care unit‐acquired weakness ( ICU ‐ AW ). However, we do not know the cut‐off point for the diagnosis of ICU ‐ AW . Aim: To ascertain the best cut‐off point for CPAx to diagnose ICU ‐ AW in adult patients with mechanical ventilation. Study Design: A multicentre, prospective cross‐sectional study. Participants were recruited from five ICUs in China that ranged from 20 June 2021 to 31 July 2023. The Medical Research Council Sum Scale ( MRC ‐ss) max ). The kappa (κ) test was used to test the consistency of the MRC ‐ss and CPAx . Results: The AUC at baseline, weaning and discharge time point was 0.87 (95% CI 0.81–0.93), 0.96 (95% CI 0.92–0.99) and 0.91 (95% CI 0.86–0.96), respectively. Correspondingly, The YImax was 0.62, 0.91 and 0.65. The best cut‐off point of CPAx score to diagnose ICU ‐ AW at baseline, weaning and discharge time point was 30.5 (sensitivity = 72%, specificity = 89%), 31.5 (sensitivity = 95%, specificity = 90%) and 31.5 (sensitivity = 94%, specificity = 71%), respectively. Due to the CPAx being an ordinal scale, it was determined preliminarily that the cut‐off point for the CPAx to diagnose ICU ‐ AW was 31 points. We took CPAx ≤31 and MRC ‐ss <48 as criteria to diagnose ICU ‐ AW and test the consistency of MRC ‐ss and CPAx . The results showed that there was no significant difference in the incidence of ICU ‐ AW at different time points. Conclusions: The optimal cut‐off point for the CPAx to diagnose ICU ‐ AW is a score of 31 and it has good sensitivity and specificity. Relevance to Clinical Practice: The CPAx ≤31 score to diagnose ICU‐acquired weakness (ICU‐AW) has good sensitivity and specificity, and it can help to predict the risk of ICU‐AW and guide medical personnel to make interventions.
- Open Access
- 5 September 2022
- Published by Springer Nature in Critical Care
- Vol. 26 (1) , 1-15
Efficacy and safety of unrestricted visiting policy for critically ill patients: a meta-analysis
Aim: To compare the safety and effects of unrestricted visiting policies (UVPs) and restricted visiting policies (RVPs) in intensive care units (ICUs) with respect to outcomes related to delirium, infection, and mortality. Methods: MEDLINE, Cochrane Library, Embase, Web of Science, CINAHL, CBMdisc, CNKI, Wanfang, and VIP database records generated from their inception to 22 January 2022 were searched. Randomized controlled trials and quasi-experimental studies were included. The main outcomes investigated were delirium, ICU-acquired infection, ICU mortality, and length of ICU stay. Two reviewers independently screened studies, extracted data, and assessed risks of bias. Random‑effects and fixed-effects meta‑analyses were conducted to obtain pooled estimates, due to heterogeneity. Meta-analyses were performed using RevMan 5.3 software. The results were analyzed using odds ratios (ORs), 95% confidence intervals (CIs), and standardized mean differences (SMDs). Results: Eleven studies including a total of 3741 patients that compared UVPs and RVPs in ICUs were included in the analyses. Random effects modeling indicated that UVPs were associated with a reduced incidence of delirium (OR = 0.4, 95% CI 0.25–0.63, I2 = 71%, p = 0.0005). Fixed-effects modeling indicated that UVPs did not increase the incidences of ICU-acquired infections, including ventilator-associated pneumonia (OR = 0.96, 95% CI 0.71–1.30, I2 = 0%, p = 0.49), catheter-associated urinary tract infection (OR 0.97, 95% CI 0.52–1.80, I2 = 0%, p = 0.55), and catheter-related blood stream infection (OR = 1.15, 95% CI 0.72–1.84, I2 = 0%, p = 0.66), or ICU mortality (OR = 1.03, 95% CI 0.83–1.28, I2 = 49%, p = 0.12). Forest plotting indicated that UVPs could reduce the lengths of ICU stays (SMD = − 0.97, 95% CI − 1.61 to 0.32, p = 0.003). Conclusion: The current meta-analysis indicates that adopting a UVP may significantly reduce the incidence of delirium in ICU patients, without increasing the risks of ICU-acquired infection or mortality. Further large-scale, multicenter studies are needed to confirm these indications.
- 5 September 2022
- Published by Springer Nature in Critical Care
- Vol. 26 (1) , 1-15
Open AccessEfficacy and safety of unrestricted visiting policy for critically ill patients: a meta-analysis
Aim: To compare the safety and effects of unrestricted visiting policies (UVPs) and restricted visiting policies (RVPs) in intensive care units (ICUs) with respect to outcomes related to delirium, infection, and mortality. Methods: MEDLINE, Cochrane Library, Embase, Web of Science, CINAHL, CBMdisc, CNKI, Wanfang, and VIP database records generated from their inception to 22 January 2022 were searched. Randomized controlled trials and quasi-experimental studies were included. The main outcomes investigated were delirium, ICU-acquired infection, ICU mortality, and length of ICU stay. Two reviewers independently screened studies, extracted data, and assessed risks of bias. Random‑effects and fixed-effects meta‑analyses were conducted to obtain pooled estimates, due to heterogeneity. Meta-analyses were performed using RevMan 5.3 software. The results were analyzed using odds ratios (ORs), 95% confidence intervals (CIs), and standardized mean differences (SMDs). Results: Eleven studies including a total of 3741 patients that compared UVPs and RVPs in ICUs were included in the analyses. Random effects modeling indicated that UVPs were associated with a reduced incidence of delirium (OR = 0.4, 95% CI 0.25–0.63, I2 = 71%, p = 0.0005). Fixed-effects modeling indicated that UVPs did not increase the incidences of ICU-acquired infections, including ventilator-associated pneumonia (OR = 0.96, 95% CI 0.71–1.30, I2 = 0%, p = 0.49), catheter-associated urinary tract infection (OR 0.97, 95% CI 0.52–1.80, I2 = 0%, p = 0.55), and catheter-related blood stream infection (OR = 1.15, 95% CI 0.72–1.84, I2 = 0%, p = 0.66), or ICU mortality (OR = 1.03, 95% CI 0.83–1.28, I2 = 49%, p = 0.12). Forest plotting indicated that UVPs could reduce the lengths of ICU stays (SMD = − 0.97, 95% CI − 1.61 to 0.32, p = 0.003). Conclusion: The current meta-analysis indicates that adopting a UVP may significantly reduce the incidence of delirium in ICU patients, without increasing the risks of ICU-acquired infection or mortality. Further large-scale, multicenter studies are needed to confirm these indications.
- Open Access
Chinesisation, adaptation and validation of the Chelsea Critical Care Physical Assessment Tool in critically ill patients: a cross-sectional observational study
Purpose To translate and adapt the Chelsea Critical Care Physical Assessment Tool (CPAx) into Chinese version (‘CPAx-Chi’), test the reliability and validity of CPAx-Chi, and verify the cut-off point for the diagnosis of intensive care unit-acquired weakness (ICU-AW). Study design Cross-sectional observational study. Methods Forward and back translation, cross-cultural adaptation and pretesting of CPAx into CPAx-Chi were based on the Brislin model. Participants were recruited from the general ICU of five third-grade class-A hospitals in western China. Two hundred critically ill adult patients (median age: 53 years; 64% men) with duration of ICU stay ≥48 hours and Glasgow Coma Scale ≥11 were included in this study. Two researchers simultaneously and independently assessed eligible patients using the Medical Research Council Muscle Score (MRC-Score) and CPAx-Chi. Results The content validity index of items was 0.889. The content validity index of scale was 0.955. Taking the MRC-Score scale as standard, the criterion validity of CPAx-Chi was r=0.758 (pConclusions CPAx-Chi demonstrated content validity, criterion-related validity and reliability. CPAx-Chi showed the best accuracy in assessment of patients at risk of ICU-AW with good sensitivity and specificity at a recommended cut-off of 31.
Open AccessChinesisation, adaptation and validation of the Chelsea Critical Care Physical Assessment Tool in critically ill patients: a cross-sectional observational study
Purpose To translate and adapt the Chelsea Critical Care Physical Assessment Tool (CPAx) into Chinese version (‘CPAx-Chi’), test the reliability and validity of CPAx-Chi, and verify the cut-off point for the diagnosis of intensive care unit-acquired weakness (ICU-AW). Study design Cross-sectional observational study. Methods Forward and back translation, cross-cultural adaptation and pretesting of CPAx into CPAx-Chi were based on the Brislin model. Participants were recruited from the general ICU of five third-grade class-A hospitals in western China. Two hundred critically ill adult patients (median age: 53 years; 64% men) with duration of ICU stay ≥48 hours and Glasgow Coma Scale ≥11 were included in this study. Two researchers simultaneously and independently assessed eligible patients using the Medical Research Council Muscle Score (MRC-Score) and CPAx-Chi. Results The content validity index of items was 0.889. The content validity index of scale was 0.955. Taking the MRC-Score scale as standard, the criterion validity of CPAx-Chi was r=0.758 (pConclusions CPAx-Chi demonstrated content validity, criterion-related validity and reliability. CPAx-Chi showed the best accuracy in assessment of patients at risk of ICU-AW with good sensitivity and specificity at a recommended cut-off of 31.
- Open Access
- 4 September 2020
- Published by Springer Nature in Research Square
Reliability, Validity, and Cutoff Point of the Chinese Version of the Chelsea Critical Care Physical Assessment Tool in Critically Ill Patients
Purpose: Translation and cross-cultural adaptation of the Chelsea Critical Care Physical Assessment Tool (CPAx) into a Chinese version of CPAx (“CPAx-Chi”), test the reliability and validity of CPAx-Chi, and verify the cutoff point for the diagnosis of intensive care unit-acquired weakness (ICU-AW) Material and methods: Translation and cross-cultural adaptation of CPAx into CPAx-Chi was based on the Brislin model. Participants were recruited from the general ICU of five third-grade class-A hospitals in western China. Adult patients (n = 200) 48 h after receiving intensive care were included (median age, 53 years; 64% males). Patients were assessed by two assessment scales: Medical Research Council Muscle Score (MRC-Score) and CPAx-Chi.Results: The item-level content validity was 0.889. The scale-level content validity was 0.955. Taking the MRC-Score scale as standard, the criterion validity of CPAx-Chi was r = 0.758 (p < 0.001) for Researcher A, and r = 0.65 (p < 0.001) for Researcher B. Cronbach’s ɑ was 0.939. The inter-rater reliability was 0.902 (p < 0.001). The AUC of CPAx-Chi for diagnosing ICU-AW based on MRC-Score ≤48 was 0.899 (95%CI 0.862–1.025) and 0.874 (0.824–0.925) for Researcher B. The maximum value of the Youden Index was 0.643, and the best cutoff point for CPAx-Chi for the diagnosis of ICU-AW was 31.5. The sensitivity was 87% and specificity was 77% for Researcher A, whereas it was 0.621, 31.5, 75%, and 87% for Researcher B, respectively. The consistency was high when taking CPAx-Chi ≤31 and MRC-Score ≤48 as the cutoff points for the diagnosis of ICU-AW. Also, kappa = 0.845 (p = 0.02) in Researcher A and 0.839 (p = 0.04) for Researcher B. Conclusions: CPAx-Chi had good content validity, criterion-related validity and reliability. CPAx-Chi showed the best accuracy in assessment of patients at risk for ICU-AW with good sensitivity and specificity at a recommended cutoff of 31.
- 4 September 2020
- Published by Springer Nature in Research Square
Open AccessReliability, Validity, and Cutoff Point of the Chinese Version of the Chelsea Critical Care Physical Assessment Tool in Critically Ill Patients
Purpose: Translation and cross-cultural adaptation of the Chelsea Critical Care Physical Assessment Tool (CPAx) into a Chinese version of CPAx (“CPAx-Chi”), test the reliability and validity of CPAx-Chi, and verify the cutoff point for the diagnosis of intensive care unit-acquired weakness (ICU-AW) Material and methods: Translation and cross-cultural adaptation of CPAx into CPAx-Chi was based on the Brislin model. Participants were recruited from the general ICU of five third-grade class-A hospitals in western China. Adult patients (n = 200) 48 h after receiving intensive care were included (median age, 53 years; 64% males). Patients were assessed by two assessment scales: Medical Research Council Muscle Score (MRC-Score) and CPAx-Chi.Results: The item-level content validity was 0.889. The scale-level content validity was 0.955. Taking the MRC-Score scale as standard, the criterion validity of CPAx-Chi was r = 0.758 (p < 0.001) for Researcher A, and r = 0.65 (p < 0.001) for Researcher B. Cronbach’s ɑ was 0.939. The inter-rater reliability was 0.902 (p < 0.001). The AUC of CPAx-Chi for diagnosing ICU-AW based on MRC-Score ≤48 was 0.899 (95%CI 0.862–1.025) and 0.874 (0.824–0.925) for Researcher B. The maximum value of the Youden Index was 0.643, and the best cutoff point for CPAx-Chi for the diagnosis of ICU-AW was 31.5. The sensitivity was 87% and specificity was 77% for Researcher A, whereas it was 0.621, 31.5, 75%, and 87% for Researcher B, respectively. The consistency was high when taking CPAx-Chi ≤31 and MRC-Score ≤48 as the cutoff points for the diagnosis of ICU-AW. Also, kappa = 0.845 (p = 0.02) in Researcher A and 0.839 (p = 0.04) for Researcher B. Conclusions: CPAx-Chi had good content validity, criterion-related validity and reliability. CPAx-Chi showed the best accuracy in assessment of patients at risk for ICU-AW with good sensitivity and specificity at a recommended cutoff of 31.